Author Archives: admin

Expected to launch in May 2022, the novel system addresses traumatic tendon lacerations in the hand, wrist, and forearm CoNextions Inc., an innovator in tendon repair, is pleased to announce that CoNextions TR Tendon Repair System has received FDA 510(k) Clearance. Expected to launch in May 2022, the novel system addresses traumatic tendon lacerations in […]

The Phantom X system uses muscle-sensing implant technology to enable greater mobility in people with orthopedic injuries. SALT LAKE CITY and AUSTIN, Texas, April 26, 2022 /PRNewswire/ — Blackrock Neurotech, an  industry leader in brain-computer interface (BCI) technology, and Phantom Neuro, a recently launched neurotech startup that delivers a high accuracy system for lifelike control of robotic […]

Highlights: Revenue of $164.9 million for the quarter ended March 31, 2022 Excluding revenue from divested businesses, revenue increased 11% year-over-year Diluted GAAP earnings per share (EPS) of $(0.26) and adjusted EPS of $(0.03) in the first quarter of 2022 improved by $0.26 and $0.03 year-over-year, respectively Ended the quarter with $339.2 million in cash, […]

FRANKLIN LAKES, N.J., May 5, 2022 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its second quarter of fiscal year 2022, which ended March 31, 2022. Revenue of $5.0 billion increased 2.1% as reported and 3.9% on currency-neutral basis Revenue driven by base revenue growth of […]

Scientific Advisory Board Will Review Company Innovation Pipeline and Advise on Emerging Trends in Health Care, Science and Technology FRANKLIN LAKES, N.J., May 2, 2022 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the inaugural members of the BD Scientific Advisory Board (SAB), which is comprised […]

The innovation blooming in Utah’s BioHive was on full display Wednesday at a ribbon-cutting ceremony announcing a new home and new name for Cibus Biotechnologies. Under the new name, Seek Labs, the company has moved to a new location at Salt Lake City’s Northgate. The new location offers expanded laboratory facilities and room to grow. […]

Senator Orrin Hatch, who served 42 years in the Senate and is the longest serving Senator in Utah’s history, died at 88 last Saturday. He is remembered fondly by Utah’s life sciences industry as a stalwart champion for medical innovation and improving the lives of patients. Reflecting on the Senator’s life and legacy, Kelvyn Cullimore, […]

BioUtah is pleased to recognize Rare Disease Day, designated as February 28. There are approximately 7,000 rare diseases, affecting an estimated 25 million to 30 million Americans. Only five percent of these diseases have a treatment. The mantra of the National Organization for Rare Disorders (NORD) – “Alone we are rare. Together we are strong” […]

In this year’s legislative session, two bills could be problematic for life sciences companies in Utah. HB60 prohibits employers from requiring proof of vaccination from employees or patrons. While it provides an exemption for federally regulated entities like hospitals, it does not provide an exemption for life sciences employees who interact with those institutions who […]

Life Sciences Day on Capitol Hill was held on February 16 filling the Capitol rotunda with 24 companies showcasing their innovations to lawmakers and collectively, reflecting the strength of Utah’s BioHive. Lt. Governor Deidre Henderson was on hand to personally visit with company representatives and learn about the important work they’re doing to advance healthcare. […]

Originally published by IONIQ Sciences Dear IONIQ Sciences Shareholders and Friends, Greetings from IONIQ Sciences where we continue to follow the science and invest in exceptional team members, advisors and consultants to help us modernize early-stage cancer detection.  LUNG Cancer – we have submitted our application to the FDA!! We have formally submitted our De Novo application to […]

Salt Lake City, UT, February 2, 2022 – IONIQ Sciences, Inc. (“IONIQ” or the “Company”) announced today that it has filed a De Novo application with the U.S. Food and Drug Administration (the “FDA”) for its IONIQ ProLung Test™ used for lung cancer. Mr. Jared Bauer, IONIQ Sciences CEO, stated, “Today we submitted our De […]